News and Media

Latest News Release

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


Company News

Cardinal Health To Enhance Offerings For Retail Independent Pharmacies With Proposed Acquisition Of The Pharmaceutical Wholesale Distribution Business From The F. Dohmen Co.

DUBLIN, Ohio, May 1, 2006— Cardinal Health, Inc. (NYSE: CAH), the leading provider of products and services supporting the health care industry, today announced plans to acquire the pharmaceutical wholesale distribution business from The F. Dohmen Co. and certain of its subsidiaries (“F. Dohmen Wholesale”). The F. Dohmen Co. is a privately held family-owned health care services corporation, headquartered in Germantown, Wisconsin. 


With revenue of approximately $1.7 billion, F. Dohmen Wholesale is the fifth largest pharmaceutical distributor in the U.S. and serves more than 2,400 independent pharmacy and retail-chain customers in the Upper Midwestern, Central, Southern and Southeast States. The company has 480 employees and four distribution centers.


”F. Dohmen Wholesale is a good fit with Cardinal Health as we continue to build the industry’s best global supply chain for pharmacy customers,” said Mark Parrish, president and chief operating officer of Supply Chain Services – Pharmaceutical at Cardinal Health.  “The acquisition will complement our existing suite of services and enhance our value proposition to retail pharmacy customers, a very important set of customers for Cardinal Health.”


“After careful consideration, we selected Cardinal Health as a partner that could successfully continue the tradition of excellence that The F. Dohmen Co. has spent 148 years cultivating,” said John Dohmen, chief executive officer and president of The F. Dohmen Co. “Cardinal Health has crafted its programs and services with the independent pharmacist in mind and will afford our customers new tools to support their continued growth and success.”


The proposed sale supports The F. Dohmen Co.’s long-term corporate strategy of focusing on rapidly growing service sectors within healthcare. The company remains committed to providing and expanding its array of health care services through The F. Dohmen Co.’s strong portfolio of remaining businesses – RESTAT, JASCORP and DDN Pharmaceutical Logistics.


Independent retail pharmacies represent an $80 billion business in the U.S., providing a vital service to patients and communities.  With this acquisition, Cardinal Health sees opportunities to grow its business in this area with a wide range of differentiated product and service solutions. Cardinal Health and F. Dohmen Wholesale have complementary capabilities and geographies that will create synergies for the two organizations and help independent retail pharmacies continue to improve their growth as they do today with Cardinal Health’s private-label products and innovative solutions.


Cardinal Health anticipates that it will complete the acquisition by June 1.  Terms of the agreement were not disclosed. 



About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $75 billion, global company serving the health-care industry with a broad portfolio of products and services.  Through its diverse offering, Cardinal Health delivers integrated health-care solutions that help customers reduce their costs, improve efficiency and deliver better care to patients.  The company manufactures, packages and distributes pharmaceuticals and medical supplies, offers a range of clinical services and develops automation products that improve the management and delivery of supplies and medication for hospitals, physician offices and pharmacies.  Ranked No. 19 on the Fortune 500, Cardinal Health employs more than 55,000 people on six continents.  More information about the company may be found at

More Company News

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...


By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health


Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...


Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields